Patent · US Active

Method of lyophilizing liposomes

US10835492B2 · kind B2 · utility

1Cited by

9References

15Claims

0Family size

Assignee

Celator Pharmaceuticals, Inc. · US

Inventors

Donna Cabral-Lilly · Princeton, US
Lawrence Mayer · Vancouver, CA
Paul Tardi · Surrey, CA
David WATKINS · East Greenwich, US
Yi Zeng · Chengdu, CN

Key dates

Filing date	Nov 5, 2018
Grant date	Nov 17, 2020
Priority date	—
Expiry date	Nov 28, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Lyophilized liposomal formulations with two or more encapsulated drugs are disclosed. These formulations display superior drug retention profiles and also maintain size distribution following lyophilization and reconstitution.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.